Chronic Myelomonocyte Leukemia clinical trials

Explore recruiting chronic myelomonocyte leukemia clinical trials.

Also recruiting in Europe

Chronic Myelomonocyte Leukemia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Precision therapy versus standard therapy in Acute Myeloid Leukaemia and Myelodysplastic syndrome in elderly (PALM) – a phase II randomized clinical trial

Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

Chronic Myelomonocyte Leukemia trials by city

Chronic Myelomonocyte Leukemia in Toronto Chronic Myelomonocyte Leukemia in Vancouver Chronic Myelomonocyte Leukemia in Montreal Chronic Myelomonocyte Leukemia in Calgary Chronic Myelomonocyte Leukemia in Edmonton Chronic Myelomonocyte Leukemia in Ottawa Chronic Myelomonocyte Leukemia in Winnipeg Chronic Myelomonocyte Leukemia in Quebec City Chronic Myelomonocyte Leukemia in Hamilton Chronic Myelomonocyte Leukemia in Kitchener Chronic Myelomonocyte Leukemia in London Chronic Myelomonocyte Leukemia in Halifax Chronic Myelomonocyte Leukemia in New York Chronic Myelomonocyte Leukemia in Los Angeles Chronic Myelomonocyte Leukemia in Chicago Chronic Myelomonocyte Leukemia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease